세계의 급성 췌장염 시장 규모, 점유율, 성장 분석 : 진단별, 원인별, 치료별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global Acute Pancreatitis Market size was valued at USD 5.8 billion in 2023 and is poised to grow from USD 6.14 billion in 2024 to USD 9.72 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global acute pancreatitis market is evolving rapidly, fueled by rising case numbers and significant medical advancements. This severe pancreatic inflammation poses serious health risks, resulting in a growing demand for effective diagnosis, treatment, and management solutions. Key market drivers include increased prevalence attributed to risk factors like obesity, alcohol consumption, and gallstones, alongside improvements in diagnostic technologies and novel therapeutic options. The sector is highly competitive, with pharmaceutical firms, medical device manufacturers, and healthcare providers actively engaged in research, clinical trials, and strategic alliances to enhance their offerings. Continuous innovation and collaboration are anticipated to shape the market's future, aiming to improve patient outcomes and address the complexities associated with this critical health condition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acute Pancreatitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Acute Pancreatitis Market Segmental Analysis

Global Acute Pancreatitis Market is segmented by Diagnosis, Cause, Treatment, End user and region. Based on Diagnosis, the market is segmented into Imaging Tests and Laboratory Tests. Based on Cause, the market is segmented into Gallstones, Alcohol and Others. Based on Treatment, the market is segmented into Intravenous fluid, Nutritional support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market is expected to experience significant growth driven by the rising prevalence of diabetes, which can be exacerbated by pancreatitis as it damages insulin-producing cells in the pancreas. Approximately 45% of individuals with chronic pancreatitis eventually develop diabetes, highlighting a crucial link between these conditions. Furthermore, the market is supported by an aging population and proactive government initiatives aimed at enhancing awareness and education regarding pancreatic health. Additionally, changing consumer lifestyles, increasing obesity rates, and the potential rise in pancreatic cancer cases will further contribute to the expansion of the Acute Pancreatitis market.

Restraints in the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market faces several significant restraints that may hinder its growth. One of the primary challenges is the high cost associated with treatment, which can limit accessibility for patients. Furthermore, developing economies may struggle with inadequate healthcare infrastructure, complicating treatment access and reducing market expansion potential. Additionally, a stringent regulatory environment adds another layer of complexity, while poor reimbursement practices deter patients from seeking necessary care. Lastly, a lack of public awareness about Acute Pancreatitis further stifles market growth, as it reduces the urgency for innovative treatments and interventions. These factors collectively contribute to a slow market development trajectory.

Market Trends of the Global Acute Pancreatitis Market

The global acute pancreatitis market is currently experiencing notable trends that emphasize early diagnosis and personalized treatment strategies. Increased investment in advanced diagnostic technologies aims to facilitate the swift identification of acute pancreatitis, allowing for timely therapeutic intervention and reduced complication rates. Furthermore, there is a rising inclination towards precision medicine, driven by advancements in genetic profiling and molecular diagnostics that allow for customized treatment plans. Additionally, the integration of digital health solutions is revolutionizing patient management and monitoring. Collectively, these trends are driving innovation in therapies, improving patient outcomes, and enhancing overall care in the acute pancreatitis landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Acute Pancreatitis Market Size by Diagnosis & CAGR (2025-2032)

• Market Overview
• Imaging Tests
• Laboratory Tests

Global Acute Pancreatitis Market Size by Cause & CAGR (2025-2032)

• Market Overview
• Gallstones
• Alcohol
• Others

Global Acute Pancreatitis Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Intravenous fluid
• Nutritional support
• Analgesics
• Endoscopic Retrograde Cholangiopancreatography (ERCP)
• Others

Global Acute Pancreatitis Market Size by End user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Centers
• Others

Global Acute Pancreatitis Market Size & CAGR (2025-2032)

• North America (Diagnosis, Cause, Treatment, End user)
  • US
  • Canada
• Europe (Diagnosis, Cause, Treatment, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnosis, Cause, Treatment, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnosis, Cause, Treatment, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnosis, Cause, Treatment, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CalciMedica Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCM Lifescience (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Bioepis (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNT Pharma Co. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceuticals (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations